Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsAvailable · provider snapshot
Research sections7 of 9 availableMissing source values remain unavailable, never zero-filled.
AI and Advanced
AI analysis and Advanced tools for KOBO
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
BSE reported results · INR crore
Metric
Jun-24
Mar-24
FY23-24
Net Profit
-1.33
-1.26
-4.93
EPS
-0.56
-0.53
-2.07
Cash EPS
Not available
-0.1
-0.36
Fundamentals
Valuation and ratios
Valuation data unavailable.
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.
Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
Peer data unavailable in the company profile payload.
Shareholding
Ownership
Promoter and promoter group
44.95%
Public shareholders
55.05%
Other shareholders
0.00%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
Not available
Company facts
Industry
Commodity Chemicals
Sector
Commodities
Website
www. avonlifesciences.com
Address
Plot No. 121A/ 1, Western Hills, Addagutta Society, Opp. JNTU, Kukatpally, , Hyderabad, Telangana, 500072
NSE Code
KOBO
BSE Code
531541
Listing date
27 Mar 2000
Face value
10
Market lot
1
CIN
L24110TG1993PLC016112
Company email
info@kobobiotech.com
Company phone
022-4287 1210
Leadership and officers
Non-Executive - Non Independent Director-Chairperson related to Promoter
Mr. AJIT KAMATH
Non-Executive - Non Independent Director
Mr. RAJENDRAKUMAR KAIMAL
Non-Executive - Independent Director
Mr. SUNIL PITRODA
Non-Executive - Independent Director
Mrs. URJA SHAH
Chief Financial Officer
Mr. Neelam Kumar Murdia
Questions
Stock FAQ
What is the symbol and ISIN of Kobo Biotech Ltd-$?
Kobo Biotech Ltd-$ has the symbol KOBO and ISIN - INE881A01015.
What is the current price of Kobo Biotech Ltd-$?
Kobo Biotech Ltd-$ is currently trading at INR 5.61.
What are the year high and year low of Kobo Biotech Ltd-$?
Kobo Biotech Ltd-$ has a year high of INR 9.08 and a year low of INR 4.19.
What is the market capitalization of Kobo Biotech Ltd-$?
Kobo Biotech Ltd-$ has a market capitalization of INR 13.37 crore.
What is the P/E ratio of Kobo Biotech Ltd-$?
Kobo Biotech Ltd-$ has a P/E ratio of NA.
What is the dividend yield of Kobo Biotech Ltd-$?
Kobo Biotech Ltd-$ has a dividend yield of NA.
How is the financial performance of Kobo Biotech Ltd-$ based on revenue, net income, and EPS?
Kobo Biotech Ltd-$ has revenue of NA, net income of INR -1.33 crore, and EPS of NA.
What is the book value of Kobo Biotech Ltd-$?
Kobo Biotech Ltd-$ has a book value of NA.
What is the debt-to-equity ratio of Kobo Biotech Ltd-$?
Kobo Biotech Ltd-$ has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Kobo Biotech Ltd-$?
Kobo Biotech Ltd-$ has a price-to-book ratio of NA and a price-to-sales ratio of NA.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.